Thomas Donner

1.4k total citations
11 papers, 490 citations indexed

About

Thomas Donner is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Thomas Donner has authored 11 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Thomas Donner's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (4 papers). Thomas Donner is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (4 papers). Thomas Donner collaborates with scholars based in United States, Türkiye and Spain. Thomas Donner's co-authors include Brian Kirkpatrick, Enric Esmatjes, Miquel Bernardo, Azucena Justicia, Emilio Fernández-Egea, Eduard Parellada, Clemente García‐Rizo, Ignacio Conget, Abdel Rahim A. Hamad and Kagan E. Karakus and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas Donner

11 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Donner United States 9 227 135 99 98 78 11 490
Emily Y. Liu United States 8 85 0.4× 130 1.0× 60 0.6× 93 0.9× 59 0.8× 8 379
Katharina Paulmichl Austria 9 94 0.4× 36 0.3× 24 0.2× 81 0.8× 106 1.4× 14 462
A Scheen Belgium 7 168 0.7× 122 0.9× 36 0.4× 62 0.6× 128 1.6× 11 426
Gloria Vega Colombia 8 98 0.4× 55 0.4× 17 0.2× 40 0.4× 61 0.8× 11 323
Tonghua Zang China 10 159 0.7× 19 0.1× 54 0.5× 66 0.7× 96 1.2× 12 523
Denise G. von Mühlen United States 10 510 2.2× 72 0.5× 129 1.3× 147 1.5× 45 0.6× 11 848
L. Della Casa Italy 9 241 1.1× 57 0.4× 56 0.6× 85 0.9× 59 0.8× 16 375
Małgorzata Saryusz‐Wolska Poland 9 84 0.4× 77 0.6× 15 0.2× 32 0.3× 98 1.3× 18 386
Elisabetta Scarano Italy 7 96 0.4× 23 0.2× 80 0.8× 38 0.4× 84 1.1× 11 359
Merav Catalogna Israel 13 102 0.4× 76 0.6× 20 0.2× 48 0.5× 43 0.6× 24 453

Countries citing papers authored by Thomas Donner

Since Specialization
Citations

This map shows the geographic impact of Thomas Donner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Donner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Donner more than expected).

Fields of papers citing papers by Thomas Donner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Donner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Donner. The network helps show where Thomas Donner may publish in the future.

Co-authorship network of co-authors of Thomas Donner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Donner. A scholar is included among the top collaborators of Thomas Donner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Donner. Thomas Donner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Abusamaan, Mohammed S., et al.. (2022). Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: A case report and review of the literature. SHILAP Revista de lepidopterología. 10(3). e05650–e05650. 5 indexed citations
2.
Ahmed, Rizwan, et al.. (2019). Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment. World Journal of Diabetes. 11(1). 13–25. 87 indexed citations
3.
4.
Bach, Richard G., Maria M. Brooks, M. Lombardero, et al.. (2013). Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation. 128(8). 785–794. 51 indexed citations
5.
Hamad, Abdel Rahim A., et al.. (2012). The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Frontiers in Immunology. 3. 196–196. 16 indexed citations
6.
Donner, Thomas, et al.. (2012). Update on Insulin Therapy for Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 97(5). 1405–1413. 37 indexed citations
7.
Joshi, Parag H., Rita R. Kalyani, Roger S. Blumenthal, & Thomas Donner. (2012). Cardiovascular Effects of Noninsulin, Glucose-Lowering Agents: Need for More Outcomes Data. The American Journal of Cardiology. 110(9). 32B–42B. 5 indexed citations
8.
9.
Chapa, Deborah, Chi‐Wen Kao, Deborah E. Jones, et al.. (2009). Depression, quality of life, and glycemic control in individuals with type 2 diabetes. Journal of the American Academy of Nurse Practitioners. 21(4). 214–224. 48 indexed citations
10.
Fernández-Egea, Emilio, Miquel Bernardo, Thomas Donner, et al.. (2009). Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. The British Journal of Psychiatry. 194(5). 434–438. 199 indexed citations
11.
Donner, Thomas. (2006). Tight control of hyperglycemia in type 2 diabetes mellitus. 1(4). 166–172. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily Y. Liu Breakdown of academic impact, for papers by Katharina Paulmichl Breakdown of academic impact, for papers by A Scheen Breakdown of academic impact, for papers by Gloria Vega Breakdown of academic impact, for papers by Tonghua Zang Breakdown of academic impact, for papers by Denise G. von Mühlen Breakdown of academic impact, for papers by L. Della Casa Breakdown of academic impact, for papers by Małgorzata Saryusz‐Wolska Breakdown of academic impact, for papers by Elisabetta Scarano Breakdown of academic impact, for papers by Merav Catalogna
Rankless by CCL
2026